Acp-101
Payments companies reported to CMS as associated with Acp-101. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Acp-101, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Acp-101
These are the largest totals companies reported as associated with Acp-101. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daiva Bajorunas | Pompano Beach, FL | $8,250.00 | |
| Elaine Wirrell | Rochester, MN | Epilepsy | $6,250.00 |
| Deepan Singh | Glen Oaks, NY | Psychiatry | $4,800.00 |
| Lynne Bird | San Diego, CA | Clinical Genetics (M.D.) | $4,000.00 |
| Diane Stafford | Palo Alto, CA | Pediatric Endocrinology | $4,000.00 |
| Edward Dabrowski | Roseville, MI | Physical Medicine & Rehabilitation | $3,900.00 |
| Shawn Mccandless | Aurora, CO | Clinical Genetics (M.D.) | $3,500.00 |
| David Repaske | Charlottesville, VA | Pediatric Endocrinology | $3,300.00 |
| Kathryn Obrynba | Columbus, OH | Pediatric Endocrinology | $3,300.00 |
| Sani Roy | Fort Worth, TX | Pediatric Endocrinology | $3,000.00 |
Prescribed Acp-101?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.